Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Bristol Myers Squibb CO Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $81.3 Billion
- Q2 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 2,901,220 shares of BMY stock, worth $154 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
2,901,220
Previous 2,577,178
12.57%
Holding current value
$154 Million
Previous $140 Million
13.79%
% of portfolio
0.15%
Previous 0.19%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,428Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.92 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.44 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.86 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.97 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.14 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $113B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...